PlainRecalls
FDA Drug Low Class III Terminated

Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15

Reported: October 17, 2018 Initiated: October 3, 2018 #D-0012-2019

Product Description

Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15

Reason for Recall

Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.

Details

Units Affected
2880 bottles
Distribution
Nationwide with the United States
Location
Hauppauge, NY

Frequently Asked Questions

What product was recalled?
Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15. Recalled by InvaGen Pharmaceuticals, Inc.. Units affected: 2880 bottles.
Why was this product recalled?
Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 17, 2018. Severity: Low. Recall number: D-0012-2019.